Jeffrey Poulton
Director of Finance/CFO presso ALNYLAM PHARMACEUTICALS, INC.
Patrimonio netto: 4 M $ in data 29/02/2024
Profilo
Jeffrey V. Poulton è un amministratore indipendente di Homology Medicines, Inc. e un direttore finanziario e contabile di Alnylam Pharmaceuticals, Inc. Fa parte del consiglio di amministrazione di Homology Medicines, Inc., Alnylam UK Ltd. e EIP Pharma, Inc. Poulton è stato precedentemente impiegato come direttore finanziario presso Indigo Agriculture, Inc. e come direttore finanziario e direttore esecutivo presso Shire Plc. Si è laureato alla Duke University e ha conseguito un MBA alla Kelley School of Business.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
01/03/2024 | 27 276 ( 0.02% ) | 4 M $ | 29/02/2024 | |
CERVOMED INC.
-.--% | 16/08/2023 | 0 ( -.--% ) | - $ | 29/02/2024 |
-.--% | 14/06/2023 | 0 ( -.--% ) | - $ | 29/02/2024 |
Posizioni attive di Jeffrey Poulton
Società | Posizione | Inizio |
---|---|---|
ALNYLAM PHARMACEUTICALS, INC. | Director of Finance/CFO | 13/08/2019 |
CERVOMED INC. | Director/Board Member | 16/08/2023 |
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Director/Board Member | - |
Alnylam UK Ltd.
Alnylam UK Ltd. BiotechnologyHealth Technology Founded in 2002, Alnylam UK Ltd. is a subsidiary of Alnylam Pharmaceuticals, Inc. that develops biotechnology products. The private company is based in Maidenhead, UK. | Director/Board Member | 13/08/2019 |
Precedenti posizioni note di Jeffrey Poulton
Società | Posizione | Fine |
---|---|---|
Indigo Ag, Inc.
Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Director of Finance/CFO | 01/04/2019 |
SHIRE | Director of Finance/CFO | 31/12/2017 |
Q32 BIO INC. | Director/Board Member | - |
Formazione di Jeffrey Poulton
Duke University | Undergraduate Degree |
Kelley School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 6 |
---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Health Technology |
Homology Medicines, Inc.
Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA. | Health Technology |
Alnylam UK Ltd.
Alnylam UK Ltd. BiotechnologyHealth Technology Founded in 2002, Alnylam UK Ltd. is a subsidiary of Alnylam Pharmaceuticals, Inc. that develops biotechnology products. The private company is based in Maidenhead, UK. | Health Technology |
CervoMed, Inc. | |
Indigo Ag, Inc.
Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Health Technology |